Stay updated on Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial
Sign up to get notified when there's something new on the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page.

Latest updates to the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page
- Check6 days agoChange DetectedA new study location in Taoyuan, Taiwan (333) has been added, broadening recruitment options. The rheumatoid arthritis topic and a Taoyuan District reference were removed from related topics, affecting the page's metadata and tagging.SummaryDifference0.1%

- Check13 days agoChange DetectedThis reflects a minor update to the ClinicalTrials.gov page’s site revision number (from v3.5.2 to v3.5.3). No study-related information appears to be changed.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded Gurgaon, India, 122001 to the study locations and removed Gūrgaon, India, 122001; updated page revision from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Rheumatoid arthritis as a related topic and a MedlinePlus Genetics link to the page. These additions provide extra context and navigation but do not alter the study content or user interactions.SummaryDifference0.0%

- Check41 days agoChange DetectedPublication added: Integrated Safety Analysis of Filgotinib in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis Over a Treatment Duration of up to 5 Years, Mod Rheumatol, 2026.SummaryDifference0.0%

- Check49 days agoChange DetectedDifference0.1%

Stay in the know with updates to Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page.